Comparing Integer (NYSE:ITGR) and Profusa (NASDAQ:PFSA)

Profusa (NASDAQ:PFSA – Get Free Report) and Integer (NYSE:ITGR – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation.

Institutional and Insider Ownership

9.8% of Profusa shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 15.0% of Profusa shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Profusa and Integer, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profusa 1 0 0 0 1.00
Integer 0 13 1 0 2.07

Integer has a consensus target price of $109.86, suggesting a potential downside of 13.32%. Given Integer’s stronger consensus rating and higher possible upside, analysts clearly believe Integer is more favorable than Profusa.

Risk and Volatility

Profusa has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500. Comparatively, Integer has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500.

Earnings and Valuation

This table compares Profusa and Integer”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Profusa $100,000.00 5.18 -$35.82 million ($5,619.96) -0.00
Integer $1.85 billion 2.32 $102.81 million $3.66 34.63

Integer has higher revenue and earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Profusa and Integer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Profusa N/A N/A -1,731.09%
Integer 6.97% 12.79% 6.48%

Summary

Integer beats Profusa on 11 of the 13 factors compared between the two stocks.

About Profusa

(Get Free Report)

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

About Integer

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Receive News & Ratings for Profusa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profusa and related companies with MarketBeat.com's FREE daily email newsletter.